vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Digimarc CORP is the larger business by last-quarter revenue ($8.9M vs $7.0M, roughly 1.3× Lakeside Holding Ltd). Lakeside Holding Ltd runs the higher net margin — -22.6% vs -47.2%, a 24.6% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 2.9%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

DMRC vs LSH — Head-to-Head

Bigger by revenue
DMRC
DMRC
1.3× larger
DMRC
$8.9M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+92.1% gap
LSH
95.0%
2.9%
DMRC
Higher net margin
LSH
LSH
24.6% more per $
LSH
-22.6%
-47.2%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
LSH
LSH
Revenue
$8.9M
$7.0M
Net Profit
$-4.2M
$-1.6M
Gross Margin
63.5%
27.2%
Operating Margin
-48.2%
-21.3%
Net Margin
-47.2%
-22.6%
Revenue YoY
2.9%
95.0%
Net Profit YoY
51.4%
18.7%
EPS (diluted)
$-0.18
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
LSH
LSH
Q4 25
$8.9M
$7.0M
Q3 25
$7.6M
$6.1M
Q2 25
$8.0M
$6.3M
Q1 25
$9.4M
$3.8M
Q4 24
$8.7M
$3.6M
Q3 24
$9.4M
$4.1M
Q2 24
$10.4M
Q1 24
$9.9M
Net Profit
DMRC
DMRC
LSH
LSH
Q4 25
$-4.2M
$-1.6M
Q3 25
$-8.2M
$-1.4M
Q2 25
$-8.2M
$-893.1K
Q1 25
$-11.7M
$-1.1M
Q4 24
$-8.6M
$-1.9M
Q3 24
$-10.8M
$-1.3M
Q2 24
$-9.3M
Q1 24
$-10.3M
Gross Margin
DMRC
DMRC
LSH
LSH
Q4 25
63.5%
27.2%
Q3 25
58.3%
18.2%
Q2 25
58.8%
26.7%
Q1 25
65.0%
18.8%
Q4 24
60.8%
-1.2%
Q3 24
62.4%
12.8%
Q2 24
66.1%
Q1 24
62.5%
Operating Margin
DMRC
DMRC
LSH
LSH
Q4 25
-48.2%
-21.3%
Q3 25
-109.7%
-20.8%
Q2 25
-105.2%
-8.9%
Q1 25
-128.9%
-28.2%
Q4 24
-105.1%
-55.6%
Q3 24
-120.4%
-32.5%
Q2 24
-96.2%
Q1 24
-109.2%
Net Margin
DMRC
DMRC
LSH
LSH
Q4 25
-47.2%
-22.6%
Q3 25
-106.9%
-22.2%
Q2 25
-102.6%
-14.2%
Q1 25
-125.2%
-28.2%
Q4 24
-99.9%
-54.1%
Q3 24
-113.9%
-32.7%
Q2 24
-89.3%
Q1 24
-104.0%
EPS (diluted)
DMRC
DMRC
LSH
LSH
Q4 25
$-0.18
$-0.08
Q3 25
$-0.38
$-0.09
Q2 25
$-0.38
$-0.11
Q1 25
$-0.55
$-0.14
Q4 24
$-0.40
$-0.26
Q3 24
$-0.50
$-0.18
Q2 24
$-0.43
Q1 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$12.9M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$40.2M
$12.2M
Total Assets
$53.0M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
LSH
LSH
Q4 25
$12.9M
$1.6M
Q3 25
$12.6M
$4.5M
Q2 25
$16.1M
$5.0M
Q1 25
$21.6M
$1.5M
Q4 24
$28.7M
$1.1M
Q3 24
$33.7M
$2.7M
Q2 24
$41.5M
Q1 24
$48.9M
Total Debt
DMRC
DMRC
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
DMRC
DMRC
LSH
LSH
Q4 25
$40.2M
$12.2M
Q3 25
$41.4M
$7.0M
Q2 25
$46.5M
$2.8M
Q1 25
$50.0M
$749.8K
Q4 24
$61.4M
$1.6M
Q3 24
$70.2M
$3.6M
Q2 24
$77.2M
Q1 24
$84.5M
Total Assets
DMRC
DMRC
LSH
LSH
Q4 25
$53.0M
$24.3M
Q3 25
$55.4M
$18.6M
Q2 25
$60.7M
$14.4M
Q1 25
$66.5M
$9.9M
Q4 24
$75.8M
$9.8M
Q3 24
$85.0M
$10.8M
Q2 24
$93.4M
Q1 24
$99.7M
Debt / Equity
DMRC
DMRC
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
LSH
LSH
Operating Cash FlowLast quarter
$991.0K
$-453.5K
Free Cash FlowOCF − Capex
$895.0K
FCF MarginFCF / Revenue
10.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
LSH
LSH
Q4 25
$991.0K
$-453.5K
Q3 25
$-2.6M
$-4.0M
Q2 25
$-4.7M
$-483.7K
Q1 25
$-5.5M
$-238.3K
Q4 24
$-4.2M
$-530.2K
Q3 24
$-7.1M
$-1.4M
Q2 24
$-6.8M
Q1 24
$-8.4M
Free Cash Flow
DMRC
DMRC
LSH
LSH
Q4 25
$895.0K
Q3 25
$-2.8M
Q2 25
$-4.9M
$-497.4K
Q1 25
$-5.5M
Q4 24
$-4.2M
$-560.5K
Q3 24
$-7.2M
$-1.4M
Q2 24
$-6.9M
Q1 24
$-8.5M
FCF Margin
DMRC
DMRC
LSH
LSH
Q4 25
10.0%
Q3 25
-36.9%
Q2 25
-61.0%
-7.9%
Q1 25
-59.1%
Q4 24
-49.1%
-15.6%
Q3 24
-75.7%
-34.5%
Q2 24
-66.1%
Q1 24
-85.8%
Capex Intensity
DMRC
DMRC
LSH
LSH
Q4 25
1.1%
Q3 25
2.9%
Q2 25
2.5%
0.2%
Q1 25
0.6%
0.0%
Q4 24
0.2%
0.8%
Q3 24
0.7%
0.1%
Q2 24
0.3%
Q1 24
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons